{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T13:58:02Z","timestamp":1760623082612,"version":"3.37.3"},"reference-count":43,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2018,5,29]],"date-time":"2018-05-29T00:00:00Z","timestamp":1527552000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K23HL125697"],"award-info":[{"award-number":["K23HL125697"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0197700","type":"journal-article","created":{"date-parts":[[2018,5,29]],"date-time":"2018-05-29T17:26:45Z","timestamp":1527614805000},"page":"e0197700","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":22,"title":["Plasma levels of high density lipoprotein cholesterol and outcomes in chronic thromboembolic pulmonary hypertension"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8506-4676","authenticated-orcid":true,"given":"Ghaleb","family":"Khirfan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vickram","family":"Tejwani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaofeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manshi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"DiDonato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raed A.","family":"Dweik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas","family":"Smedira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gustavo A.","family":"Heresi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2018,5,29]]},"reference":[{"issue":"25 Suppl","key":"ref1","doi-asserted-by":"crossref","first-page":"D34","DOI":"10.1016\/j.jacc.2013.10.029","article-title":"Updated clinical classification of pulmonary hypertension","volume":"62","author":"G Simonneau","year":"2013","journal-title":"Journal of the American College of Cardiology"},{"issue":"6","key":"ref2","doi-asserted-by":"crossref","first-page":"970","DOI":"10.3324\/haematol.2009.018960","article-title":"Prospective cardiopulmonary screening program to detect chronic thromboembolic pulmonary hypertension in patients after acute pulmonary embolism","volume":"95","author":"FA Klok","year":"2010","journal-title":"Haematologica"},{"issue":"22","key":"ref3","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1056\/NEJMoa032274","article-title":"Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism","volume":"350","author":"V Pengo","year":"2004","journal-title":"The New England journal of medicine"},{"issue":"10","key":"ref4","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1164\/rccm.200712-1841OC","article-title":"Improved outcomes in medically and surgically treated chronic thromboembolic pulmonary hypertension","volume":"177","author":"R Condliffe","year":"2008","journal-title":"American journal of respiratory and critical care medicine"},{"issue":"1","key":"ref5","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.athoracsur.2012.04.004","article-title":"Pulmonary endarterectomy: recent changes in a single institution\u2019s experience of more than 2,700 patients","volume":"94","author":"MM Madani","year":"2012","journal-title":"The Annals of thoracic surgery"},{"issue":"25 Suppl","key":"ref6","doi-asserted-by":"crossref","first-page":"D60","DOI":"10.1016\/j.jacc.2013.10.031","article-title":"Updated treatment algorithm of pulmonary arterial hypertension","volume":"62","author":"N Galie","year":"2013","journal-title":"Journal of the American College of Cardiology"},{"issue":"3","key":"ref7","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.jtcvs.2010.11.024","article-title":"Surgical management and outcome of patients with chronic thromboembolic pulmonary hypertension: results from an international prospective registry","volume":"141","author":"E Mayer","year":"2011","journal-title":"The Journal of thoracic and cardiovascular surgery"},{"issue":"4","key":"ref8","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1056\/NEJMoa1209655","article-title":"Riociguat for the treatment of pulmonary arterial hypertension","volume":"369","author":"HA Ghofrani","year":"2013","journal-title":"The New England journal of medicine"},{"issue":"143","key":"ref9","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0119-2016","article-title":"Balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension","volume":"26","author":"I Lang","year":"2017","journal-title":"European respiratory review: an official journal of the European Respiratory Society"},{"issue":"5","key":"ref10","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1164\/rccm.201001-0007OC","article-title":"Plasma levels of high-density lipoprotein cholesterol and outcomes in pulmonary arterial hypertension","volume":"182","author":"GA Heresi","year":"2010","journal-title":"American journal of respiratory and critical care medicine"},{"issue":"2","key":"ref11","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.amjcard.2016.04.028","article-title":"Usefulness of High-Density Lipoprotein Cholesterol to Predict Survival in Pulmonary Arterial Hypertension","volume":"118","author":"CM Larsen","year":"2016","journal-title":"The American journal of cardiology"},{"issue":"3","key":"ref12","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.amjcard.2012.03.042","article-title":"Serum high-density lipoprotein cholesterol levels as a prognostic indicator in patients with idiopathic pulmonary arterial hypertension","volume":"110","author":"QH Zhao","year":"2012","journal-title":"The American journal of cardiology"},{"issue":"10","key":"ref13","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1161\/01.ATV.0000094961.74697.54","article-title":"Endothelial protection by high-density lipoproteins: from bench to bedside","volume":"23","author":"L Calabresi","year":"2003","journal-title":"Arteriosclerosis, thrombosis, and vascular biology"},{"issue":"1","key":"ref14","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1161\/01.ATV.21.1.13","article-title":"High density lipoproteins and arteriosclerosis. Role of cholesterol efflux and reverse cholesterol transport","volume":"21","author":"A von Eckardstein","year":"2001","journal-title":"Arteriosclerosis, thrombosis, and vascular biology"},{"issue":"22","key":"ref15","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1161\/01.CIR.0000103624.14436.4B","article-title":"Inflammatory\/antiinflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favorably affected by simvastatin treatment","volume":"108","author":"BJ Ansell","year":"2003","journal-title":"Circulation"},{"issue":"1","key":"ref16","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0021-9150(99)00186-0","article-title":"Constantly low HDL-cholesterol concentration relates to endothelial dysfunction and increased in vivo LDL-oxidation in healthy young men","volume":"147","author":"JO Toikka","year":"1999","journal-title":"Atherosclerosis"},{"issue":"11","key":"ref17","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1161\/01.ATV.14.11.1775","article-title":"HDL and apolipoprotein A-I protect erythrocytes against the generation of procoagulant activity","volume":"14","author":"RM Epand","year":"1994","journal-title":"Arteriosclerosis and thrombosis: a journal of vascular biology"},{"issue":"2","key":"ref18","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1172\/JCI5006","article-title":"High-density lipoprotein enhancement of anticoagulant activities of plasma protein S and activated protein C","volume":"103","author":"JH Griffin","year":"1999","journal-title":"The Journal of clinical investigation"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1146\/annurev.physiol.64.081501.155952","article-title":"Regulation of endothelial nitric oxide synthase: location, location, location","volume":"64","author":"PW Shaul","year":"2002","journal-title":"Annual review of physiology"},{"issue":"7","key":"ref20","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/89986","article-title":"High-density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthase","volume":"7","author":"IS Yuhanna","year":"2001","journal-title":"Nature medicine"},{"issue":"6","key":"ref21","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1161\/01.CIR.81.6.1784","article-title":"Prostaglandin I2 half-life regulated by high density lipoprotein is decreased in acute myocardial infarction and unstable angina pectoris","volume":"81","author":"T Aoyama","year":"1990","journal-title":"Circulation"},{"issue":"3","key":"ref22","doi-asserted-by":"crossref","first-page":"C739","DOI":"10.1152\/ajpcell.00055.2011","article-title":"Human apolipoprotein A-I induces cyclooxygenase-2 expression and prostaglandin I-2 release in endothelial cells through ATP-binding cassette transporter A1","volume":"301","author":"D Liu","year":"2011","journal-title":"American journal of physiology Cell physiology"},{"issue":"1","key":"ref23","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0049-3848(97)00189-8","article-title":"Hyperalphalipoproteinemia and prostaglandin I2 stability","volume":"88","author":"C Pirich","year":"1997","journal-title":"Thrombosis research"},{"issue":"3","key":"ref24","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1172\/JCI113682","article-title":"Serum prostacyclin stabilizing factor is identical to apolipoprotein A-I (Apo A-I). A novel function of Apo A-I","volume":"82","author":"Y Yui","year":"1988","journal-title":"The Journal of clinical investigation"},{"issue":"1","key":"ref25","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","article-title":"2015 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT)","volume":"37","author":"N Galie","year":"2016","journal-title":"European heart journal"},{"issue":"1","key":"ref26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"28","author":"RM Lang","year":"2015","journal-title":"Journal of the American Society of Echocardiography: official publication of the American Society of Echocardiography"},{"issue":"2","key":"ref27","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1513\/AnnalsATS.201608-605OC","article-title":"Abnormal Glucose Metabolism and High-Energy Expenditure in Idiopathic Pulmonary Arterial Hypertension","volume":"14","author":"GA Heresi","year":"2017","journal-title":"Annals of the American Thoracic Society"},{"issue":"1","key":"ref28","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1161\/CIRCRESAHA.113.301141","article-title":"Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension","volume":"115","author":"M Rabinovitch","year":"2014","journal-title":"Circulation research"},{"issue":"1","key":"ref29","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1161\/CIRCRESAHA.115.301130","article-title":"The metabolic theory of pulmonary arterial hypertension","volume":"115","author":"R Paulin","year":"2014","journal-title":"Circulation research"},{"issue":"15","key":"ref30","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/0002-9149(91)90274-O","article-title":"Effects of high-density lipoprotein on acetylcholine-induced coronary vasoreactivity","volume":"68","author":"FE Kuhn","year":"1991","journal-title":"The American journal of cardiology"},{"issue":"2","key":"ref31","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1056\/NEJM199207093270202","article-title":"An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension","volume":"327","author":"BW Christman","year":"1992","journal-title":"The New England journal of medicine"},{"issue":"4","key":"ref32","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1056\/NEJM199507273330403","article-title":"Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension","volume":"333","author":"A Giaid","year":"1995","journal-title":"The New England journal of medicine"},{"issue":"7","key":"ref33","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S2213-2600(14)70089-X","article-title":"Chronic thromboembolic pulmonary hypertension","volume":"2","author":"MM Hoeper","year":"2014","journal-title":"The Lancet Respiratory medicine"},{"issue":"Suppl 3","key":"ref34","doi-asserted-by":"crossref","first-page":"S215","DOI":"10.1513\/AnnalsATS.201509-620AS","article-title":"The Pathobiology of Chronic Thromboembolic Pulmonary Hypertension","volume":"13","author":"IM Lang","year":"2016","journal-title":"Annals of the American Thoracic Society"},{"issue":"3","key":"ref35","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1378\/chest.103.3.685","article-title":"Pulmonary vascular lesions occurring in patients with chronic major vessel thromboembolic pulmonary hypertension","volume":"103","author":"KM Moser","year":"1993","journal-title":"Chest"},{"issue":"2","key":"ref36","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1136\/thoraxjnl-2013-203746","article-title":"Surgical specimens, haemodynamics and long-term outcomes after pulmonary endarterectomy","volume":"69","author":"N Skoro-Sajer","year":"2014","journal-title":"Thorax"},{"issue":"3","key":"ref37","doi-asserted-by":"crossref","first-page":"e0152580","DOI":"10.1371\/journal.pone.0152580","article-title":"The Clinical Significance of HbA1c in Operable Chronic Thromboembolic Pulmonary Hypertension","volume":"11","author":"MJ Richter","year":"2016","journal-title":"PloS one"},{"issue":"5","key":"ref38","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1183\/09031936.00100407","article-title":"Heart-type fatty acid-binding protein for risk assessment of chronic thromboembolic pulmonary hypertension","volume":"31","author":"M Lankeit","year":"2008","journal-title":"The European respiratory journal"},{"issue":"11","key":"ref39","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1016\/j.rmed.2007.06.027","article-title":"Role of NT-proBNP and 6MWD in chronic thromboembolic pulmonary hypertension","volume":"101","author":"J Suntharalingam","year":"2007","journal-title":"Respiratory medicine"},{"issue":"10","key":"ref40","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.healun.2012.08.014","article-title":"HbA1c in pulmonary arterial hypertension: a marker of prognostic relevance?","volume":"31","author":"MJ Belly","year":"2012","journal-title":"The Journal of heart and lung transplantation: the official publication of the International Society for Heart Transplantation"},{"issue":"10","key":"ref41","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1161\/CIRCULATIONAHA.106.663120","article-title":"Pulmonary arterial hypertension is linked to insulin resistance and reversed by peroxisome proliferator-activated receptor-gamma activation","volume":"115","author":"G Hansmann","year":"2007","journal-title":"Circulation"},{"issue":"8","key":"ref42","first-page":"904","article-title":"Unrecognized glucose intolerance is common in pulmonary arterial hypertension","volume":"30","author":"ME Pugh","year":"2011","journal-title":"The Journal of heart and lung transplantation: the official publication of the International Society for Heart Transplantation"},{"issue":"2","key":"ref43","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1183\/09031936.00000508","article-title":"Insulin resistance in pulmonary arterial hypertension","volume":"33","author":"RT Zamanian","year":"2009","journal-title":"The European respiratory journal"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0197700","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T15:35:49Z","timestamp":1661355349000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0197700"}},"subtitle":[],"editor":[{"given":"You-Yang","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2018,5,29]]},"references-count":43,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2018,5,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0197700","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2018,5,29]]}}}